Left Ventricular Hypertrophy and Chronic Renal Insufficiency in the Elderly

Abstract

Background: The global population is aging. Cardiovascular disease is the leading cause of death in both men and women older than 65 years. In particular, elderly patients have an increased prevalence of left ventricular hypertrophy (LVH) and chronic kidney disease (CKD), both of which predict increased cardiovascular morbidity and mortality. LVH and CKD frequently coexist in the elderly, and LVH is a powerful predictor of mortality in patients with end-stage renal disease. Key Messages: Several hemodynamic factors contribute to LVH and CKD in the elderly. Increased arterial stiffness in the elderly is associated with LVH and CKD. Studies using noninvasive measures of arterial stiffening have shown a correlation between these measures and LVH in patients with CKD. Hypertensive patients with an altered circadian blood pressure pattern such as nondippers have an increased incidence of LVH and CKD. Anemia is a risk factor for LVH in patients in all stages of CKD, and studies have shown correlations between age, anemia and LV mass. Nonhemodynamic factors include chronic inflammation, increased oxidative stress, and reduced autophagy, all of which are present in the elderly. Disordered mineral metabolism in the elderly with reduced levels of vitamin D and elevated levels of parathyroid hormone and phosphorus is associated with LVH and CKD. Conclusions: Multiple pathophysiologic mechanisms contribute to the development of LVH and CKD in the elderly. Future research should be directed at interfering with this development and reducing the burden of cardiovascular and renal diseases in this growing population. i 2014 S. Karger AG, Basel

The link between bone disease and cardiovascular complications in hemodialysis patients

“…Also, PTH activates kinase C protein in cardiomyocytes, causing an increase in cellular mass. It has been noted that parathyroidectomy can cause a decrease in LV mass, and this finding supports the role of elevated PTH levels in the development of LVH ( 30 ). Patients with chronic kidney disease are exposed to another bone disease before or after developing kidney disease, i.e., osteoporosis, which is a common disease that is characterized by low bone mass and skeletal fragility resulting in an increased risk of fracture ( 31 ).…”

Global diastolic strain rate for the assessment of left ventricular diastolic dysfunction in young peritoneal dialysis patients: a case control study

“…It appears that nonatherosclerotic processes, including left ventricular hypertrophy and fibrosis, account for most of the excess cardiovascular risk in uremic patients [13]. Equally, the increased pressure, volume overload, anemia, hypocalcemia, and hyperphosphatemia usually result in compensatory myocardial hypertrophy and fibrosis, making diastolic dysfunction seem to be more common and occur earlier than systolic dysfunction in young uremic patients [14][15][16]. Furthermore, in our previous study, we found that patients with the normal LVEF, although under long-term regular peritoneal dialysis, maintaining well-controlled blood pressure and stable ultrafiltration and adequate total fluid removal, their LV diastolic function deteriorated as the CKD progressed, in contrast to the stable LV systolic function [17].…”

Left Ventricular Strain and Dyssynchrony in Young and Middle-Aged Peritoneal Dialysis Patients and Healthy Controls: A Case-Matched Study

“…Because of the increase of pressure and volume overload, early cardiac function damage is mainly due to compensatory hypertrophy of the myocardium in PD patients [6]. At that time, there is no obvious change in cardiac cavity size and systolic function, and it is still within the normal Values are presented as mean ± SD.…”